Dexmedetomidine Induced Polyuria in the Intensive Care Unit

Area of Science:

• Critical Care Medicine
• Pharmacology
• Endocrinology

Background:

• Dexmedetomidine is an alpha2-adrenergic agonist used for sedation in intensive care units (ICUs).
• Polyuria is a known, though infrequent, side effect associated with dexmedetomidine, typically observed in perioperative settings.
• Central diabetes insipidus (CDI) is characterized by inadequate antidiuretic hormone production or release, leading to excessive urination.

Observation:

• A 61-year-old male patient in the medical ICU developed significant polyuria.
• The patient had received intravenous dexmedetomidine infusion for sedation.
• The polyuria was attributed to the development of central diabetes insipidus.

Findings:

• Dexmedetomidine administration was identified as the likely cause of central diabetes insipidus in this ICU patient.
• This represents an uncommon presentation of dexmedetomidine's side effect profile within the ICU setting.
• The diagnosis of drug-induced CDI can be challenging due to its rarity in this context.

Implications:

• Increased clinical awareness of dexmedetomidine-induced polyuria and CDI is crucial for early recognition.
• Prompt diagnosis and management of this adverse effect can prevent complications associated with fluid and electrolyte imbalances.
• This case underscores the importance of considering medication side effects in complex ICU patient presentations.